Continue antiretroviral therapy during virologic failure?

Clin Infect Dis. 2002 Feb 15;34(4):553-6. doi: 10.1086/338017.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antiretroviral Therapy, Highly Active*
  • CD4 Lymphocyte Count
  • Drug Resistance, Microbial / genetics
  • HIV Infections / drug therapy
  • HIV Infections / immunology*
  • HIV-1 / drug effects
  • Humans
  • Treatment Failure